{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:16:55Z","timestamp":1790713015776,"version":"4.1.0"},"reference-count":30,"publisher":"Scientific Scholar","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n            <jats:title>Background &amp; objectives:<\/jats:title>\n            <jats:p>Psoriasis is a recurrent hyper-proliferative skin disease which is often associated with free radical generation, abnormal lipid metabolism and increased inflammatory secretion that induce cardiovascular risk in these patients. The present study was intended to evaluate serum lipids, lipoprotein and oxidants-antioxidants status and to establish their relationship with atherogenic risk markers [oxidized low-density lipoprotein (oxLDL) and high-sensitivity C-reactive protein (hsCRP)] in patients with psoriasis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The study was conducted on 150 psoriasis patients and 150 age- and sex-matched healthy controls. Overnight fasting blood samples were obtained for lipids, lipoproteins, lipid oxidation and peroxidation products [oxLDL, malondialdehyde (MDA)], antioxidant enzymes [reduced glutathione (GSH) and total antioxidant status] levels and hsCRP estimations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>The mean levels of atherogenic lipids [total cholesterol (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), triacylglycerol (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01)], lipid peroxidation products (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) and oxLDL and hsCRP (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) levels in patients with psoriasis were found to be significantly higher than those of healthy controls. On the other hand, ferric-reducing ability of plasma (FRAP, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) and antioxidant enzyme activities (reduced GSH, <jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.01) were significantly lower when compared to healthy controls. The plasma oxLDL was positively correlated to LDL cholesterol (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) and MDA (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) and negatively associated with antioxidant status in these patients. Serum MDA, FRAP and oxLDL were correlated with risk of atherosclerosis in the patients with psoriasis; however, no significant association was found between reduced GSH and hsCRP.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interpretation &amp; conclusions:<\/jats:title>\n            <jats:p>The study results suggest that LDL oxidation and reactive oxygen species in addition to inflammatory markers may play a pivotal role in inducing atherosclerosis in patients of psoriasis.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_717_16","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T08:42:57Z","timestamp":1523608977000},"page":"708-713","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":44,"title":["Dyslipidaemia &amp; oxidative stress in patients of psoriasis"],"prefix":"10.25259","volume":"146","author":[{"given":"Kumari","family":"Asha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Singal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suman Bala","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod Kumar","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amitesh","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-7-20241212","first-page":"169","article-title":"Psoriasis","volume":"1","author":"Gudjonsson","year":"2008"},{"key":"R2-7-20241212","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0891-5849(00)00482-2","article-title":"Redox-modulated pathways in inflammatory skin diseases","volume":"30","author":"Fuchs","year":"2001","journal-title":"Free Radic Biol Med"},{"key":"R3-7-20241212","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/15230860260220175","article-title":"Oxidative stress and its role in skin disease","volume":"4","author":"Trouba","year":"2002","journal-title":"Antioxid Redox Signal"},{"key":"R4-7-20241212","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3349\/ymj.2003.44.6.987","article-title":"Oxidant\/antioxidant status in patients with psoriasis","volume":"44","author":"Baz","year":"2003","journal-title":"Yonsei Med J"},{"key":"R5-7-20241212","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.ATV.15.5.551","article-title":"The response-to-retention hypothesis of early atherogenesis","volume":"15","author":"Williams","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R6-7-20241212","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/eurheartj\/ehr425","article-title":"Psoriasis and atherosclerosis: Two plaques, one syndrome?","volume":"33","author":"Flammer","year":"2012","journal-title":"Eur Heart J"},{"key":"R7-7-20241212","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4103\/2229-5178.193906","article-title":"Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring","volume":"7","author":"Dogra","year":"2016","journal-title":"Indian Dermatol Online J"},{"key":"R8-7-20241212","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/1756-185X.12134","article-title":"Metabolic syndrome in psoriatic arthritis patients: A cross-sectional study","volume":"16","author":"Sharma","year":"2013","journal-title":"Int J Rheum Dis"},{"key":"R9-7-20241212","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4103\/0019-5154.113958","article-title":"Is psoriasis a new cutaneous marker for metabolic syndrome? A study in Indian patients","volume":"58","author":"Khunger","year":"2013","journal-title":"Indian J Dermatol"},{"key":"R10-7-20241212","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/eurheartj\/ehu403","article-title":"Cardiovascular disease in patients with chronic inflammation: Mechanisms underlying premature cardiovascular events in rheumatologic conditions","volume":"36","author":"Mason","year":"2015","journal-title":"Eur Heart J"},{"key":"R11-7-20241212","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrrheum.2012.14","article-title":"Accelerated atherosclerosis in patients with SLE -mechanisms and management","volume":"8","author":"Skaggs","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R12-7-20241212","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/jid.2013.131","article-title":"Psoriasis is not associated with atherosclerosis and incident cardiovascular events: The Rotterdam study","volume":"133","author":"Dowlatshahi","year":"2013","journal-title":"J Invest Dermatol"},{"key":"R13-7-20241212","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome - A new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"R14-7-20241212","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jdds.2015.05.002","article-title":"Psoriasis: Correlation between severity index (PASI) and quality of life index (DLQI) based on the type of treatment","volume":"20","author":"Ali","year":"2016","journal-title":"J Dermatol Dermatol Surg"},{"key":"R15-7-20241212","doi-asserted-by":"crossref","first-page":"21","DOI":"10.14712\/18059694.2014.4","article-title":"Association of carotid intima-media thickness with leptin and apoliprotein b\/apoliprotein a-I ratio reveals imminent predictors of subclinical atherosclerosis in psoriasis patients","volume":"57","author":"Asha","year":"2014","journal-title":"Acta Medica (Hradec Kralove"},{"key":"R17-7-20241212","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"for American Heart Association & National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome: An American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"R18-7-20241212","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0009-9120(95)02043-8","article-title":"Simple methods of quantifying oxidation products and antioxidant potential of low density lipoproteins","volume":"29","author":"Ahotupa","year":"1996","journal-title":"Clin Biochem"},{"key":"R19-7-20241212","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0009-8981(78)90081-5","article-title":"Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method","volume":"90","author":"Satoh","year":"1978","journal-title":"Clin Chim Acta"},{"key":"R20-7-20241212","first-page":"882","article-title":"Improved method for the determination of blood glutathione","volume":"61","author":"Beutler","year":"1963","journal-title":"J Lab Clin Med"},{"key":"R21-7-20241212","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1006\/abio.1996.0292","article-title":"The ferric reducing ability of plasma (FRAP) as a measure of \u201cantioxidant power\u201d: The FRAP assay","volume":"239","author":"Benzie","year":"1996","journal-title":"Anal Biochem"},{"key":"R22-7-20241212","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/j.1365-2133.2004.05984.x","article-title":"The inflammatory response in mild and in severe psoriasis","volume":"150","author":"Rocha-Pereira","year":"2004","journal-title":"Br J Dermatol"},{"key":"R23-7-20241212","first-page":"WC01","article-title":"Prevalence of metabolic syndrome in psoriasis patients and its relation to disease duration: A hospital based case-control study","volume":"10","author":"Praveenkumar","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"R24-7-20241212","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1515\/CCLM.2002.013","article-title":"Serum lipids and apolipoproteins in patients with psoriasis","volume":"40","author":"Uyanik","year":"2002","journal-title":"Clin Chem Lab Med"},{"key":"R25-7-20241212","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4103\/0378-6323.41390","article-title":"Role of free reactive iron in psoriasis","volume":"74","author":"Ghosh","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R26-7-20241212","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1468-3083.2003.00641.x","article-title":"The role of oxidants and antioxidants in psoriasis","volume":"17","author":"Yildirim","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"R27-7-20241212","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0009-8981(99)00150-3","article-title":"Antioxidants and lipid peroxidation status in the blood of patients with psoriasis","volume":"289","author":"K\u00f6k\u00e7am","year":"1999","journal-title":"Clin Chim Acta"},{"key":"R28-7-20241212","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s12291-010-0043-9","article-title":"Role of oxidative stress in various stages of psoriasis","volume":"25","author":"Kadam","year":"2010","journal-title":"Indian J Clin Biochem"},{"key":"R29-7-20241212","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jdermsci.2009.05.008","article-title":"Circulating levels of adiponectin, oxidized LDL and C-reactive protein in Portuguese patients with psoriasis vulgaris, according to body mass index, severity and duration of the disease","volume":"55","author":"Coimbra","year":"2009","journal-title":"J Dermatol Sci"},{"key":"R30-7-20241212","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4103\/0378-6323.163734","article-title":"Comprehensive lipid tetrad index, atherogenic index and lipid peroxidation: Surrogate markers for increased cardiovascular risk in psoriasis","volume":"81","author":"Sunitha","year":"2015","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"R31-7-20241212","first-page":"53","article-title":"Serum high sensitivity C reactive protein and homocysteine levels in patients with mild to moderate psoriasis","volume":"43","author":"Balci","year":"2009","journal-title":"Turkderm Deri Hast Frengi Ars"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201746060-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:59:37Z","timestamp":1751497177000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/dyslipidaemia-oxidative-stress-in-patients-of-psoriasis-emerging-cardiovascular-risk-factors\/"}},"subtitle":["Emerging cardiovascular risk factors"],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_717_16","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}